Product Information

EXFORGE 5-320 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $13.4557 per EA under NDC 00078049015. Its NADAC has been published 326 times since Nov 28, 2013.

FDA first approved this application on Jun 20, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EXFORGE 5-320 MG TABLET

amlodipine besylate and valsartan
$13.4557per EA

Strength

5; 320 mg/1; mg/1

NDC

00078049015

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021990

FDA Approved

6/20/2007

TE Code

AB

On Market Since

6/20/2007

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for EXFORGE 5-320 MG TABLET has been published 326 times since Nov 28, 2013, and over the history we have for it it has risen 146.9%. The table below summarizes its recorded NADAC range and movement.

Current price$13.4557 per EA
All-time high$13.4578 (Nov 11, 2026)
All-time low$5.4505 (Nov 28, 2013)
52-week high$13.4578
52-week low$13.4557
Median price$9.2366
Average price$8.7684
Largest weekly change+23.1% (Oct 21, 2026)
Weeks tracked326
Tracking sinceNov 28, 2013

Price History

1W

-0.0%

1M

-0.0%

3M

+23.1%

6M

+23.1%

1Y

+23.1%

3Y

+23.1%

5Y

+23.1%

All

+146.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amlodipine besylate and valsartan market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EXFORGE 5-320 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EXFORGE 5-320 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $13.4557 per EA (NDC 00078049015), effective Nov 18, 2026.

How has the price of EXFORGE 5-320 MG TABLET changed over time?

Over the history we have for it, the NADAC for EXFORGE 5-320 MG TABLET has risen 146.9%. It has been tracked across 326 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for EXFORGE 5-320 MG TABLET?

Since Nov 28, 2013, the NADAC for EXFORGE 5-320 MG TABLET has ranged from a low of $5.4505 (Nov 28, 2013) to a high of $13.4578 (Nov 11, 2026), with a median of $9.2366 per EA.

Are there cheaper alternatives to EXFORGE 5-320 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of EXFORGE 5-320 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures EXFORGE 5-320 MG TABLET?

EXFORGE 5-320 MG TABLET (NDC 00078049015) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.